Skip to main content
HBIO logo

HBIO · Harvard Bioscience Inc · Executive Compensation

Track HBIO — free
$8.34 +0.21 (+2.58%) At close · Oct 2
Market Cap
$36.24M
Shares
4.55M
Volume · Oct 2 15.47K Avg daily vol (3M) 17.96K

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

Fiscal 2025
Executive Total
John Duke $905,208
James W. Green $355,823
James Green $355,823
Mark Frost $343,518
Jennifer Cote $123,006
Fiscal 2024
Executive Total
James Green $2,336,576
Former Chairman $2,336,576
James W. Green $2,336,576
Jennifer Cote $602,601
Mark Frost —
John Duke —
Fiscal 2023
Executive Total
James W. Green $2,392,240
James Green $2,392,240
Jennifer Cote $571,272
Fiscal 2022
Executive Total
James W. Green $2,328,470
James Green $2,328,470
Fiscal 2021
Executive Total
James Green $2,737,454
James W. Green $2,737,454
Michael Rossi $818,750
Kenneth Olson $704,311
Fiscal 2020
Executive Total
James Green $2,620,453
James W. Green $2,620,453
Kenneth Olson $829,082
Michael Rossi $778,161
Fiscal 2019
Executive Total
James W. Green $2,280,723
James Green $2,280,723
Michael Rossi $320,547
Kenneth Olson $156,321

Executive changes

Person Change Filed
Katherine A. Eade Appointed 2026-06-02
John Duke Appointed 2026-06-02
Mark Frost Appointed 2026-03-10
Bill Snider Appointed 2025-12-17
Bill Snider Appointed 2025-12-17
William A. Snider Appointed 2025-12-17
Stephen DeNelsky Appointed 2025-09-09
Seth Benson Appointed 2025-07-17
Rob Gagnon Appointed 2025-07-17
Jim Green Retired 2025-07-17
John Duke Appointed 2025-07-17
James W. Green Resigned 2025-07-17
James W. Green Resigned 2025-07-17
James W. Green Resigned 2025-07-17
Alan Edrick Resigned 2025-06-13
John D. Duke Appointed 2025-06-02
Katherine Eade Appointed 2025-06-02
Thomas Loewald Resigned 2025-06-02
Jennifer Cote Appointed 2023-06-20
Michael Rossi Resigned 2023-01-19
Michael Rossi Resigned 2022-12-12
Key facts CIK 1123494 CUSIP 416906204 13F (30d) 1 filings 1 filers Visit website Investor relations